Open AccessErratum in: Topical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea
Publication year - 2022
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.11.8.15
Subject(s) - tofacitinib , cornea , medicine , macrophage polarization , blocking (statistics) , pharmacology , ophthalmology , immunology , macrophage , chemistry , computer science , rheumatoid arthritis , biochemistry , in vitro , computer network
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom